Average Co-Inventor Count = 12.94
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cancer Research Technology Limited (10 from 262 patents)
2. Astex Therapeutics Limited (7 from 123 patents)
10 patents:
1. 12077526 - Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
2. 12071429 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
3. 11787792 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof
4. 11603367 - Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
5. 11261171 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
6. 10981898 - Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
7. 10544132 - Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
8. 10526311 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
9. 10259806 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
10. 9663503 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof